Probiotics and Skin
Our cutaneous and intestinal microbiota have a close relation with skin health, so manipulation of these microbiota may have health benefits for the skin.
There is little direct evidence that topical or oral probiotics administered beyond the early perinatal period lead to long-term modification of the intestinal or cutaneous microbiota composition after treatment has ceased.
Nevertheless, there are promising data suggesting that probiotics administered by either route may have significant beneficial effects on the skin.
Orally ingested probiotic bacteria have been widely investigated for a potential role in treating or preventing the common skin disease eczema.
The weight of evidence suggests that some probiotic bacteria administered both prenatally and postnatally may be effective for preventing eczema, perhaps through promotion of healthy immune development.
Current evidence suggests that orally administered probiotic bacteria are not effective for the treatment of established eczema.
KeywordsIrritable Bowel Syndrome Food Allergy Allergic Rhinitis Allergic Disease Intestinal Microbiota
- Allen SJ, Okoko B, Martinez E, Gregorio G, Dans LF. Probiotics for treating infectious diarrhoea. Cochrane Database Syst Rev. 2003;4:CD003048.Google Scholar
- Aragon G, Graham DB, Borum M, Doman DB. Probiotic therapy for irritable bowel syndrome. Gastroenterol Hepatol. 2010;6(1):39–44.Google Scholar
- FAO/WHO. Guidelines for the evaluation of probiotics in food. London, Ontario, Canada; 2002.Google Scholar
- Gueniche A, Knaudt B, Schuck E, Volz T, Bastien P, Martin R, et al. Effects of nonpathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled clinical study. Br J Dermatol. 2008;159(6):1357–63.PubMedCrossRefGoogle Scholar
- Kim JY, Kwon JH, Ahn SH, Lee SI, Han YS, Choi YO, et al. Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a double-blind, randomized, placebo-controlled trial. Pediatr Allergy Immunol. 2009;21(2 Pt 2):e386–93.PubMedGoogle Scholar
- Kim JY, Kwon JH, Ahn SH, Lee SI, Han YS, Choi YO, et al. Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a double-blind, randomized, placebo-controlled trial. Pediatr Allergy Immunol. 2010;21(2 Pt 2):e386–93.PubMedCrossRefGoogle Scholar
- Metchnikoff E. Prolongation of life: optimistic studies. New York: Putnam and Sons; 1906.Google Scholar
- Peguet-Navarro J, Dezutter-Dambuyant C, Buetler T, Leclaire J, Smola H, Blum S, et al. Supplementation with oral probiotic bacteria protects human cutaneous immune homeostasis after UV exposure-double blind, randomized, placebo controlled clinical trial. Eur J Dermatol. 2008;18(5):504–11.PubMedGoogle Scholar
- Prescott SL, Wickens K, Westcott L, Jung W, Currie H, Black PN, et al. Supplementation with Lactobacillus rhamnosus or Bifidobacterium lactis probiotics in pregnancy increases cord blood interferon-gamma and breast milk transforming growth factor-beta and immunoglobin A detection. Clin Exp Allergy. 2008;38(10):1606–14.PubMedCrossRefGoogle Scholar
- Taylor AL, Dunstan JA, Prescott SL. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol. 2007;119(1):184–91.PubMedCrossRefGoogle Scholar